Gandini David Joseph 4
4 · TransBiotec, Inc. · Filed Jan 16, 2020
Insider Transaction Report
Form 4
Gandini David Joseph
DirectorChief Revenue Officer
Transactions
- Award
Common Stock Option
2019-10-25+8,000,000→ 8,000,000 totalExercise: $0.01From: 2019-10-31Exp: 2029-10-31→ Common Stock (8,000,000 underlying) - Award
Common Stock Option
2019-10-25+24,000,000→ 32,000,000 totalExercise: $0.01From: 2019-11-25Exp: 2029-11-25→ Common Stock (24,000,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Reporting Person's Employment Agreement as the Issuer's Chief Revenue Officer, the Reporting Person was issued a stock option to acquire 8,000,000 shares of the Issuer's common stock at $0.00792 per share, with 6,666,600 options vesting on October 31, 2019 and 1,333,400 options vesting on December 31, 2019. The options expire 10 years after vesting.
- [F2]Pursuant to the Reporting Person's Employment Agreement, the Reporting Person was issued a stock option to acquire 24,000,000 shares of the Issuer's common stock at an exercise price of $0.00792 per share. The shares vest in equal monthly installments of 666,666 shares per month over 36 months and expire ten years from the vesting date.